Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKinsey
Baxter
Express Scripts
Colorcon

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Adavosertib


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Adavosertib?

Adavosertib is an investigational drug.

There have been 28 clinical trials for Adavosertib. The most recent clinical trial was a Phase 1 trial, which was initiated on July 21st 2014.

The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), AstraZeneca, and Parexel.

There are thirty-one US patents protecting this investigational drug and three hundred and sixty-six international patents.

Recent Clinical Trials for Adavosertib
TitleSponsorPhase
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibParexelPhase 1
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibAstraZenecaPhase 1
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid TumoursParexelPhase 1

See all Adavosertib clinical trials

Clinical Trial Summary for Adavosertib

Top disease conditions for Adavosertib
Top clinical trial sponsors for Adavosertib

See all Adavosertib clinical trials

US Patents for Adavosertib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Adavosertib ⤷  Try it Free Remote loading of sparingly water-soluble drugs into lipid vesicles ZONEONE PHARMA, INC. (San Francisco, CA) ⤷  Try it Free
Adavosertib ⤷  Try it Free Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids Cantex Pharmaceuticals, Inc. (Weston, FL) ⤷  Try it Free
Adavosertib ⤷  Try it Free Silanol based therapeutic payloads BlinkBio, Inc. (Jupiter, FL) ⤷  Try it Free
Adavosertib ⤷  Try it Free Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer AstraZeneca AB (Sodertalje, SE) ⤷  Try it Free
Adavosertib ⤷  Try it Free Methods and compositions for treatment of cancer and autoimmune disease THE JACKSON LABORATORY (Bar Harbor, ME) ⤷  Try it Free
Adavosertib ⤷  Try it Free Silanol based therapeutic payloads BlinkBio, Inc. (Jupiter, FL) ⤷  Try it Free
Adavosertib ⤷  Try it Free Therapeutic dendrimers AstraZeneca AB (Sodertalje, SE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Adavosertib

Drugname Country Document Number Estimated Expiration Related US Patent
Adavosertib Australia AU2015301234 2034-08-04 ⤷  Try it Free
Adavosertib Canada CA2962709 2034-08-04 ⤷  Try it Free
Adavosertib China CN106999419 2034-08-04 ⤷  Try it Free
Adavosertib European Patent Office EP3177269 2034-08-04 ⤷  Try it Free
Adavosertib World Intellectual Property Organization (WIPO) WO2016022549 2034-08-04 ⤷  Try it Free
Adavosertib European Patent Office EP3258941 2035-02-17 ⤷  Try it Free
Adavosertib World Intellectual Property Organization (WIPO) WO2016133910 2035-02-17 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKinsey
Baxter
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.